Reducing levels of nicotinic alkaloids in plants

Patent metadata

Field	Value
Publication number	US-9856487-B2
Application number	US-201414444511-A
Country	US
Kind code	B2
Filing date	Jul 28, 2014
Priority date	Feb 28, 2005
Publication date	Jan 2, 2018
Grant date	Jan 2, 2018

Abstract

Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.

First claim

What is claimed is:

1. A method for reducing anatabine in a tobacco plant comprising:
introducing a cDNA molecule into the plant to genetically engineer suppression of a gene product encoded by SEQ ID NO: 1, wherein the cDNA molecule comprises a nucleotide sequence selected from the group consisting of:
(a) a nucleotide sequence set forth in SEQ ID NO: 1 or a fragment thereof of at least 20 contiguous nucleotides; and
(b) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 2; and
selecting a tobacco plant having reduced anatabine as compared to a non-transformed control plant.

2. A method for reducing anatabine in a tobacco plant comprising:
(a) introducing the cDNA molecule of claim 1 into the plant to genetically engineer suppression of a gene product encoded by SEQ ID NO: 1;
(b) genetically engineering suppression of at least an additional nicotinic alkaloid biosynthesis enzyme selected from the group consisting of NBB1, aspartate oxidase, quinolinate synthase, quinolate phosphoribosyl transferase, ornithine decarboxylase, putrescine N-methyltransferase, and diamine oxidase; and
(c) selecting a tobacco plant having reduced anatabine as compared to a non-transformed control plant.

3. The method of claim 2 , wherein the gene product encoded by SEQ ID NO: 1 and putrescine N-methyltransferase are suppressed.

4. A method for reducing total anatabine content in a tobacco plant, comprising
(a) introducing the cDNA molecule of claim 1 into the plant to genetically engineer suppression of a gene product encoded by SEQ ID NO: 1; and
(b) genetically engineering suppression of at least one additional nicotinic alkaloid biosynthesis enzyme selected from the group consisting of NBB1, aspartate oxidase, quinolinate synthase, quinolate phosphoribosyl transferase, ornithine decarboxylase, putrescine N-methyltransferase, and diamine oxidase; and
(c) selecting a tobacco plant having reduced total anatabine content as compared to a non-transformed control plant.

5. The method of claim 4 , wherein the additional nicotinic alkaloid biosynthesis enzyme is quinolate phosphoribosyl transferase.

Assignees

• 22Nd Century Ltd Llc

Inventors

• Hashimoto Takashi
• Kato Akira

Classifications

• A24B15/18 Primary

  Treatment of tobacco products or tobacco substitutes · CPC title

• A24B13/00

  Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff (reconstituted tobacco products A24B3/14) · CPC title

• C12N15/8243 Primary

  involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine · CPC title

• C12N9/001

  acting on the CH-CH group of donors (1.3) · CPC title

• A24B13/02

  Flakes or shreds of tobacco · CPC title